Chief Operating Officer, Vital Statistics Consulting
Managing Director, Co-Founder, IPQ Analytics LLC
Founder and Chief Executive Officer, Singleron Biotechnologies
Head of Medical Excellence and Omnichannel, Sanofi
Chief Executive Officer, Elixa MediScience
INTERIM HEAD OF CLINICAL OPERATIONS, Clinical Excellence GmbH
Associate Director Digital, Teva
Advisor, ekwithree
Senior Director, Boldspace
Senior Director, GSK
Global Capability Owner (GCO)- Customer Targeting & Engagement Planning, Boehringer Ingelheim
Chief Executive Officer, Eternitii Ltd.
Vice President, Managing Director, Integrated Safety, IQVIA
Head of Data, Digital & Technology Europe & Canada Oncology BU, Takeda
Founder & Chief Executive Officer, PRXchange
VP, Head Clinical Development, Grünenthal Group
Founder, Scientific Advisor, End-to-End Process Management, BiotechNmed
Principal Consultant and Founder, NewtonBio Consulting
Vice President, Frost & Sullivan
Vice President Global Market Access & Pricing, Merck
CEO , Co- Founder , Sarah Jones Coaching
Board Chair & Non – Executive Director , Suzie Harvey Consulting
Founder, GMD Bioinformatics
CEO, Co-Founder, DaltonTx
CEO, Newal R&D Ltd
Founder, Scientific Director, SERENITE- Forceville
Global Marketing Director, IPSEN
Founder & CEO, Manta Cares
Senior Director Business Development , Medable
Chief Operating Officer, – Vital Statistics Consulting
- Co-Owner & COO, Unbiased Science; Head of Global Medical Information, Recordati Rare Disease Michelle is a scientist, healthcare professional, and executive with over 20 years of experience in healthcare, pharma, biotech, and public health. She specializes in health science communications, digital and AI transformation, patient and HCP engagement, and strategic consulting, including M&A support. As Vice President Elect of Medical Information Leaders in Europe (MILE), Michelle shapes industry best practices, builds future-facing technology, and enhances access to medical information and professional education. She brings diverse expertise as a biologist, critical care nurse, pharmacy technician, and medical toxicology postgraduate, driving innovative solutions that improve operational excellence and patient outcomes.She also serves on the scientific boards of multiple tech and medical companies and leads women-led organizations Unbiased Science and Vital Statistics Consulting.
Managing Director, Co-Founder, IPQ Analytics, LLC
Dr. Liebman is a computational biologist and theoretical chemist with extensive leadership experience in academia, industry, and translational medicine. He previously served as Executive Director of the Windber Research Institute and held senior roles at Roche, Wyeth, and the University of Pennsylvania Cancer Center. He is currently Adjunct/Research Professor at Drexel College of Medicine, University of Massachusetts–Lowell, and Wenzhou/Fudan Universities. Dr. Liebman specializes in computational modeling of disease, clinical pathway analysis, and risk/benefit assessment, with applications in multiple sclerosis, heart failure, and women’s health. He is active in digital health, quantum computing, translational medicine, and serves on multiple editorial boards and advisory boards globally.
Founder and Chief Executive Officer Singleron Biotechnologies
Nan Fang is a Strategic UX/UI Design Lead at Proverb Agency, specializing in creating user-centered digital experiences. With a strong background in design, she leads initiatives that align with business goals while enhancing user satisfaction. Her work emphasizes collaboration, innovation, and a deep understanding of user needs to deliver impactful digital solutions.
Founder and Chief Executive Officer Singleron Biotechnologies
Barry Daly is a seasoned leader in pharmaceutical medical affairs, serving as Head of Medical Excellence and Omnichannel at Sanofi UKIE. He drives initiatives to enhance medical communications and digital engagement across the UK and Ireland, leveraging data and technology to improve healthcare professional (HCP) interactions. Barry’s leadership emphasizes collaboration, strategic use of data, and human-centered approaches to advance patient outcomes. He is based in Newcastle upon Tyne, England.
